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Abstract
We hypothesized that pediatric patients with type 1 diabetes have cardiac magnetic resonance (CMR)
detectable differences in thoracic aortic wall properties and hemodynamics leading to significant local
differences in indices of wall shear stress, when compared with age-matched control subjects without diabetes.
Pediatric patients with type 1 diabetes were recruited from Children’s Hospital of Wisconsin and compared with
controls. All underwent morning CMR scanning, 4-limb blood pressure, brachial artery reactivity testing, and
venipuncture. Patient-specific computational fluid dynamics modeling with fluid–structure interaction, based on
CMR data, determined regional time-averaged wall shear stress (TAWSS) and oscillatory shear index (OSI).
Twenty type 1 diabetic subjects, median age 15.8 years (11.6–18.4) and 8 controls 15.4 years (10.3–18.2) were
similar except for higher glucose, hemoglobin A1c, and triglycerides for type 1 diabetic subjects. Lower flowmediated dilation was seen for those with type 1 diabetes (6.5) versus controls (7.8), p = 0.036. For type 1
diabetic subjects, the aorta had more regions with high TAWSS when compared to controls. OSI maps appeared
similar. Flow-mediated dilation positively correlated with age at diabetes diagnosis (r = 0.468, p = 0.038) and
hemoglobin A1c (r = 0.472, p = 0.036), but did not correlate with aortic distensibility, TAWSS, or OSI. TAWSS did
not correlate with any clinical parameter for either group. CMR shows regional differences in aortic wall
properties for young diabetic patients. Some local differences in wall shear stress indices were also observed,
but a longitudinal study is now warranted.

Introduction
Cardiovascular disease afflicts greater than 83 million Americans, with coronary heart disease (CHD) affecting
more than 15 million Americans [11]. Traditional risk factors for the development of atherosclerosis include
diabetes, dyslipidemia, hypertension, obesity, smoking, and sedentary lifestyle [29]. Type 1 diabetes is
associated with a fivefold to sevenfold increase in risk of death from coronary heart disease. Patients with type 1
diabetes have been shown to have endothelial dysfunction, the inciting event for atherosclerosis [14].
Endothelial dysfunction and arterial stiffness are independent predictors of cardiovascular events; improved
endothelial function can decrease cardiovascular events [12, 15, 40]. The reduced endothelial function seen in
individuals with diabetes allows for premature integration of lipid laden macrophages in the vessel walls. In
addition, the hyperglycemic environment seen in diabetic patient results in qualitative changes in low density
lipoprotein (LDL) particle size, oxidation, and glycation—all of which are implicated in early increases in carotid
artery intimal media thickness and endothelial dysfunction [31, 41].

A special feature of CMR imaging is its ability for tissue discrimination. Clinically, magnetic resonance imaging
has been reported in adults to detect atherosclerotic plaques in the thoracic and abdominal aorta with detection
of thoracic aortic plaque associated with co-existent coronary artery disease (CAD) [38]. A study of adults with
pre-existing plaques revealed time-averaged wall shear stress (TAWSS) flow patterns in a rotating pattern down
the thoracic aorta that correlated with the areas of atherosclerotic plaque [46]. A better understanding of the
relationship between endothelial shear stress and arterial remodeling and stiffening is needed, as arterial
stiffening seems to lie at the heart of atherosclerotic plaque development [44]. While some adult studies exist,
magnetic resonance imaging studies examining the vascular health of pediatric subjects, prior to the
development of overt atherosclerotic plaque, are not found in the literature.
The purpose of our pilot, prospective study was to determine the feasibility of CMR imaging for evaluation of
early vascular changes in a pediatric cohort with type 1 diabetes, who are at increased risk of developing
atherosclerosis. We hypothesized that pediatric patients with type 1 diabetes would have CMR detectable
differences in thoracic aortic wall properties and hemodynamics leading to local differences in indices of wall
shear stress, as quantified by patient-specific computational fluid dynamics (CFD) modeling with fluid–structure
interaction, when compared with age-matched control subjects without diabetes. Correlation between CMR
data and brachial artery reactivity measures of endothelial function, as well as with other atherosclerotic risk
factors, was investigated.

Materials and Methods
Recruitment

Twenty children with type 1 diabetes, aged 12–18 years, were recruited from Children’s Hospital of Wisconsin
(CHW) Diabetes Clinic, affiliated with the Medical College of Wisconsin. Children with type 1 diabetes were
either on multiple daily insulin consisting of bedtime insulin glargine® and pre-meal aspart® insulin or continuous
subcutaneous insulin infusion with insulin aspart®. In addition, eight age-matched control subjects were
recruited consecutively from among those patients having clinically indicated CMR scans. Inclusion criteria
included pre-pubescent to post-pubescent children/adolescents between 10 and 18 years of age and at least a
2-year history of diabetes. Exclusion criteria included known history of contraindication to CMR examination
(i.e., pregnancy as determined by beta human chorionic gonadotrophin (β-hCG), presence of a pacemaker or
defibrillator, or claustrophobia), hypercholesterolemia, metabolic syndrome, hypertension, microvascular
complications, congenital heart disease (for diabetic study recruits), and family history of hypercholesterolemia
or premature cardiovascular disease. Furthermore, control subjects were excluded if taking any lipid lowering,
oral hypoglycemic, or antihypertensive medications for more than 1 week. The study protocol was approved by
the CHW institutional review board. Informed consent and assent were obtained from the study
parents/guardians and subjects.

Study Evaluations

Evaluations included early morning (0630 AM, fasting) CMR scanning using a Siemens 1.5 T Symphony® (Siemens
Medical Systems, USA) magnet, with same-day 4-limb blood pressure (BP) assessment (DASH 3000 Vital Signs
Monitor, GE Healthcare, Waukesha WI) and morning (0800) brachial artery reactivity testing with highresolution ultrasound (GE Pro Logiq 500, Waukesha WI). Subjects underwent same-day venipuncture for fasting
laboratory assessment (i.e., glucose, hemoglobin A1c, insulin, lipid profile, fibrinogen, homocysteine, highsensitivity c reactive protein (hs-CRP)) by previously described analytical methods [3]. In addition, chart review
allowed extraction of key clinical data including primary and secondary diagnoses, age at diabetes diagnosis, and
medication use for type 1 diabetic subjects.

Data Collection

Standard CMR scanning was performed using a Siemens 1.5 T Symphony magnet with study supervised by a
qualified pediatric cardiologist, using clinically available pulse sequence software (Siemens Medical Solutions
USA, Malvern, PA) with standard calculation of ventricular volumes and flow (Medis®, Leiden, The Netherlands).
For this study, the subjects did not receive gadolinium dye, but rather CMR three-dimensional (3D) steady statefree precession (SSFP) images of the arch were obtained from a respiratory navigated sequence (bandwidth 590,
matrix 256 × 173, TE 1.86, TR 298, NEX 1, acceptable window 2.5 mm). Phase contrast velocity encoded cine
imaging (FOV 256 × 192, slice thickness 5–6 mm, bandwidth 390, TE 3.26–4.1, TR 27.75–46, ETL 1, NEX 3) of flow
volume was determined for the ascending and descending aorta, as well as for each brachiocephalic vessel to be
used in later CFD modeling. Care was taken during flow assessment to select similar flow imaging planes for
each subject; thus, a plane perpendicular to AAo flow, at the level of the pulmonary arterial bifurcation, was
prescribed for AAo flow assessment and similarly a separate plane for the DAo flow assessment was undertaken
at the level of branch PAs. Aortic distensibility was calculated from measured BP and cross-sectional phase
contrast magnitude images of the ascending aorta, descending thoracic aorta, and descending thoracic aorta at
the diaphragm, using the formula [43]:
Aorticdistensibility =

[(Aorticcrosssectionalarea)max − (Aorticcrosssectionalarea)min]
.
[(Aorticcrosssectionalarea)min × pulsepressure]

Reactive hyperemia (i.e., flow-mediated dilation, FMD) was assessed for each subject after being in the supine
position for 10 min at a stable room temperature [3, 4]. The methods for determining, analyzing, and reporting
the FMD percentage (FMD%) in the brachial artery, as a surrogate of endothelial function, were performed using
mobile equipment (MicroMaxx, Sonosite, Bothell, WA) and analyzed by our research laboratory as previously
described [17, 20].
Anonymized age-matched control and type 1 diabetic subjects’ CMR data for a randomly selected pilot sub
group (7 controls, 9 subjects with type 1 diabetes) were used to create subject-specific CFD models with fluid–
structure interaction as described previously using SimVascular software package (https://simtk.org) and
discretized using MeshSim (Simmetrix, Clifton Park, NY) [22]. Pulsatile flow waveforms from the measured
ascending aortic CMR phase contrast data were applied as the inlet boundary condition for each CFD model
using fully developed parabolic profiles [22]. To replicate the resistance to blood flow from vessels beyond CMR
data, three-element Windkessel representations were imposed as outlet boundary conditions for each vascular
branch using a coupled-multidomain method [42] as previously described [22]. This method provides an intuitive
representation of the arterial tree beyond model outlets and can be described by three parameters with
physiologic meaning: characteristic (i.e., regional) resistance (R c), arterial capacitance (C), and distal resistance
(R d). Please see Table 1 for Windkessel parameters. The total arterial capacitance for each patient was
determined from inflow (i.e., CMR phase contrast) and BP measurements assuming a characteristic-to-total
resistance ratio of 6 % [24]. The total arterial capacitance was then distributed among outlets according to their
blood flow distributions [37] as measured by CMR phase contrast data of each aortic branch. Once the
capacitance terms for each branch were assigned, the terminal resistance for each branch was calculated from
mean BP (via DASH 3000) and flow (via CMR phase contrast) and distributed between the characteristic and
distal resistance parameters by adjusting Rc:terminal resistance ratios (6–10 %) to replicate measured BP using
the pulse pressure method [36]. This approach results in flow distributions and BP values within 5 % of the
measured values.
Table 1 Range of Windkessel and arterial parameters for the collection of CFD models in each group

Young’s modulus

Control

T1DM

E (dyn/cm2)
Innominate artery
R c (dynes/cm5)
C (cm5/dyn)
R d (dynes/cm5)
Left common carotid artery
R c (dynes/cm5)
C (cm5/dyn)
R d (dynes/cm5)
Left subclavian artery
R c (dynes/cm5)
C (cm5/dyn)
R d (dynes/cm5)
Descending aortic outlet
R c (dynes/cm5)
C (cm5/dyn)
R d (dynes/cm5)

3.99E+06–3.57E+07 3.23E+06–1.17E+07
429–489
320–939
1.22E−04–1.42E−04 1.23E−04–3.99E−04
4,250–6,500
4,520–9,260
687–1,720
702–1,390
3.91E−05–1.15E−04 4.94E−05–1.52E−04
10,800–19,600
11,800–15,200
662–1,830
500–1,480
6.11E−05–1.26E−04 6.19E−05–1.62E−04
6,400–23,000
6,813–15,000
99–231
101–232
2.67E−04–8.76E−04 2.84E−04–8.16E−04
894–4,580
1,530–4,710

E, Young’s modulus; R c, characteristic resistance; C, arterial capacitance; R d, distal resistance

Coupled blood flow and vessel wall dynamics were solved using a coupled-momentum method [7] formulation
and parameters discussed in detail elsewhere [22]. Briefly, CFD models were initially pre-stressed by loading the
vessel wall with the diastolic pressure, assuming that the geometry given by the collective SSFP images
approximates a diastolic (i.e., reference) configuration. Literature values for aortic thickness (0.15 cm), density
(1.0 g/cm3), and Poisson’s ratio (0.5) were selected and Young’s modulus, E, was adjusted iteratively until the
ascending aortic (AAo) mean luminal displacement was within 5 % of the values from CMR phase contrast
magnitude measurements. Please see Table 1 for the range of E used. This approach was previously found to
provide reasonable wall displacement in simulations when compared to spatially equivalent locations from CMR
phase contrast [22].
Time-dependent CFD simulations with fluid–structure interaction were performed using an in-house stabilized
finite element method with an embedded commercial linear solver LESLIB (Altair Engineering, Troy, MI) to solve
the conservation of mass (continuity), balance of fluid momentum (Navier–Stokes), and vessel wall
elastodynamics equations [7]. Meshes contained >3 million tetrahedral elements and localized refinement was
performed using an adaptive technique to deposit more elements in regions prone to flow disruption [28, 34],
which has been previously described in detail elsewhere [21]. Simulations were run for 4–6 cardiac cycles until
the flow rate and pressure fields yielded periodic solutions. For comparison with distensibility calculations, mean
TAWSS and oscillatory shear index (OSI) values were then calculated within circumferential bands, where the
thickness of the phase contrast imaging slice intersected the AAo and descending (DAoT) aorta [22, 25]. TAWSS
and OSI values were also extracted longitudinally along the inner and outer curvatures of the thoracic aorta, as
well as along its anatomic right and left sides [23]. The location of the left subclavian artery (LSCA) was taken as
the zero point for quantification, with all other aortic locations noted relative to this; aortic regions distal to the
LSCA were given positive location designation and locations proximal (i.e., closer to the aortic valve) received a
negative designation in terms of location [23].

Statistical Analyses

Medians and ranges are given for continuous demographic variables. Scatter plots and Pearson’s correlation
coefficients were used for the analyses of correlation between two measurements. A Mann–Whitney test was
used to compare the controls and subjects with type 1 diabetes.
We did not adjust for multiple testing since the power of the study is low and adjustment would increase
considerably an already high chance of a type II error.

Results
Twenty-eight subjects (age 15.7 years (11.6–18.4), 20 with type 1 diabetes age 15.8 years (11.6–18.4), and 8
controls (age 15.4 years (10.3–18.2)) were recruited from the Children’s Hospital of Wisconsin. Subjects were of
similar age, gender, and body habitus with no significant difference in resting BP (Table 2). Similarly, there were
no differences in heart rate, cardiac output, or cardiac index between groups. Control subjects underwent
clinical CMR scanning for the following indications: pectus excavatum (1 patient), to rule out arrhythmogenic
right ventricular dysplasia (ARVD) (3 patients, with study negative for ARVD in all 3), very small ventricular septal
defect (1 patient), repaired tetralogy of Fallot (1 patient), repaired pulmonary stenosis (1 patient), and
anomalous origin of the right coronary artery from the left sinus of Valsalva (1 patient). Subjects with type 1
diabetes had disease for 9.4 (2.2–13.5) years, and all were taking insulin at time of recruitment. Two patients
with diabetes were using levothyroxine and none were on lipid lowering medication at recruitment. Control
subjects were not receiving chronic medications. Significant differences were seen between the controls and
diabetic subjects for glucose, HgbA1c, and triglyceride level, but not for other venous blood values (Table 3).
Table 2 Demographics

a

Type 1 diabetic subjects (n = 20)a
Age (years)
15.8 (11.6–18.4)
Gender
10 male (50 %)
Age at diabetes diagnosis (years) 6.3 (1.1–11.1)
Diabetes duration (years)
9.4 (2.2–13. 5)
2
Body mass index (kg/m )
21.1 (14.0–34.0)
2
Body surface area (m )
1.72 (1.14–2.10)
Right arm systolic BP (mmHg)
114 (103–139)
Right arm diastolic BP (mmHg)
68 (59–77)
Heart rate (beats/min)
49 (37–58)

Control subjects (n = 8)a
15.4 (10.3–18.2)
5 male (62.5 %)
Not applicable
Not applicable
22.4 (17.3–34.3)
1.74 (1.24–2.26)
118 (101–127)
68 (56–78)
51 (39–74)

Data displayed as median and ranges; no significant differences seen (p > 0.05)

Table 3 Traditional Venous blood coronary artery disease risk factors and brachial artery measures of vascular
health

Total cholesterol (mg/dL)
LDL (mg/dL)
HDL (mg/dL)
Triglycerides (mg/dL)
Glucose (mg/dL)
Insulin level (µU/mL)

Type 1 diabetic subjects
(n = 20)a
162 (125–348)
88 (58–240)
56 (41–74)
87 (45–298)
140 (76–366)
4.0 (1–24)

Control subjects
(n = 8)a
158 (140–263)
90 (67–203)
58 (44–68)
48 (34–118)
84 (80–98)
3 (1–15)

p*
NS
NS
NS
0.003
0.001
NS

HgbA1c (mmol/mol)
Fibrinogen (mg/dL)
hs-CRP (mg/L)
Homocysteine (µmol/L)
FMD % (EKG)
Distensibilityb AAo
Distensibilityb DAoT
Distensibilityb DAoD

62 (44–119)
296 (216–464)
0.5 (0.1–22.4)
4.9 (3.4–9.1), n = 19
6.5 (1.9–13.6)
9.3 (4.3–17.2) n = 19
10.5 (4.0–20.0)
12.6 (7.4–22.9), n = 19

33 (31–40), n = 7
239 (203–365)
0.3 (0.1–2.4)
6.0 (4.5–7.1), n = 7
7.8 (6.6–9.7), n = 7
5.8 (3.1–9.5)
7.9 (4.6–17.5)
9.5 (5.1–
15.6), n = 6

< 0.001
NS
NS
NS
0.036
0.006
NS
NS

AAo ascending aorta, DAo T descending mid thoracic aorta, DAo D descending aorta at diaphragm, NS not
significant
* p > 0.05
aData displayed as median and ranges
bDistensibility was expressed as 10−3 mmHg−1
Brachial artery reactivity data showed a significant difference for FMD% between control and diabetic subjects
(p = 0.036) (Table 3). There was also a significant difference between control and diabetic subjects’ ascending
aortic distensibility (p = 0.006), but not distensibility in other regions of the aorta. FMD% positively correlated
with age at diabetes diagnosis (r = 0.468, p = 0.038) and HgbA1c (r = 0.472, p = 0.036), and negatively with years
post diagnosis (r = −0.547, p = 0.013). Brachial artery reactivity testing (FMD) did not correlate significantly with
aortic distensibility or the TAWSS and OSI results for this pilot study, though interesting qualitative differences in
TAWSS and OSI are apparent throughout the thoracic aorta (color images, Figs. 1, 2). Although no significant
differences in global TAWSS or OSI were viewed for selected AAo or DAoT imaging planes, a trend toward
significance existed for DAoT TAWSS, with diabetic patients having higher TAWSS than controls (p = 0.072)
(Table 4). OSI distributions appeared similar between groups at this stage. Looking at a more granular level, for
control subjects, the aorta had more local regions with low TAWSS (blue on color images), when compared to
type 1 diabetic patients. Specifically, along right, left, outer and, to a lesser degree, the inner curvatures of the
aorta, median TAWSS at each location for diabetics (denoted by the red line on the graphs) tended to be higher
than median TAWSS for the controls (black line). These differences reached significance at two locations, one
along the outer curvature (location 1.25) and another along the anatomic right side (location 1.5) of the aorta
(Fig. 1). For OSI, significant differences are also seen in the area distal to the take-off of the LSCA (Fig. 2) at
locations 1.5 and 2.0 along the outer curvature, and locations near 0.5 along the anatomic left side of the aorta.
For this small sub group with CFD modeling, though, neither global nor regional aortic TAWSS correlated with
any clinical or laboratory value for either the control or diabetic subjects. There was a significant correlation
between control subjects’ total cholesterol and global DAoT OSI (r = 0.767, p = 0.044). After excluding one
diabetic outlier (where hs-CRP = 22), there was a trend toward a negative correlation between hs-CRP and AAo
distensibility (r = −0.459, p = 0.064), but not distensibility in other areas, suggesting regional differences in aortic
wall properties.

Fig. 1 Collective time-averaged wall shear stress (TAWSS) distributions from CFD (top) and ensemble-averaged,
longitudinal TAWSS distributions comparing CFD models for seven control subjects (black) and nine age- and
gender-matched type 1 diabetic subjects (red) along the outer, anatomic right, anatomic left, and inner
curvatures of the aorta (bottom). The x-axis denotes location along the arch divided by the diameter at the
outlet of each patient’s model. This approach accounts for differences in aortic dimensions resulting from
differences in size between patients and was used to normalize the longitudinal locations among all patients.
The left subclavian artery (LSCA) was then taken as the zero point for quantification, with all other aortic
locations noted relative to this. Hence, aortic regions distal to the LSCA have a positive location designation and
locations proximal (i.e., closer to the aortic valve) have a negative designation in terms of their location.
Statistically different values exist when compared to control subjects (*p < 0.05). Data are expressed as medians
with bars representing lower and upper quartiles

Fig. 2 Collective oscillatory shear index (OSI) distributions from CFD (top) and ensemble-averaged, longitudinal
aortic OSI distributions comparing CFD models for seven control subjects (black) and nine age- and gender-

matched type 1 diabetic subjects (red) along the outer, anatomic right, anatomic left, and inner curvatures of
the aorta (bottom). The x-axis denotes location along the arch divided by the diameter at the outlet of each
patient’s model. This approach accounts for differences in aortic dimensions resulting from differences in size
between patients and was used to normalize the longitudinal locations among all patients. The LSCA was then
taken as the zero point for quantification, with all other aortic locations noted relative to this. Hence, aortic
regions distal to the LSCA have a positive location designation and locations proximal (i.e., closer to the aortic
valve) have a negative designation in terms of their location. Statistically different values exist when compared
to control subjects (*p < 0.05). Data are expressed as medians with bars representing lower and upper quartiles
Table 4 Novel measures of vascular health from CFD modeling

TAWSS AAo (dynes/cm2)
TAWSS DAoT (dynes/cm2)
OSI AAo
OSI DAoT

Type 1 diabetes subjects
(n = 9)a
20.4 (6.1–38.8)
28.6 (8.6–39.0)
0.16 (0.13–0.28)
0.12 (0.06–0.16)

A Ao ascending aorta, DAo T descending mid thoracic aorta
* No significant differences seen (p > 0.05)
aData displayed as median and ranges

Control subjects
(n = 7)a
16.8 (7.5–35.4)
17.9 (10.2–28.4)
0.18 (0.10–0.23)
0.15 (0.10–0.19)

p*
0.832
0.072
0.916
0.244

Discussion
Endothelial dysfunction is considered a key event in the development of atherosclerosis. Measures of
endothelial dysfunction have included brachial artery reactivity testing, pulse wave velocity assessment by radial
artery tonometry, and intimal-medial thickening assessment by ultrasound [14]. Impaired FMD response, by
brachial artery reactivity testing, has been shown to detect endothelial dysfunction in subjects with
hyperlipidemia (being especially affected by elevated total cholesterol), hypertension, and/or diabetes—
traditional cardiovascular risk factors for CAD [5, 10, 18]. The impaired brachial artery reactivity seen in our
cohort is similar to what has been seen by others. Babar et al. showed that pre-adolescent children with type 1
diabetes, and mean diabetes duration of 4 years, displayed evidence of low-intensity vascular inflammation and
attenuated FMD measurements [3]. The positive correlations seen in the present research between FMD and
subject age at diabetes diagnosis, years with diabetes, and HgbA1c, are congruent with the literature [13];
vascular health worsens with duration of poor glucose control. Furthermore, early autonomic derangements
have been observed in patients with type 1 diabetes and are believed to be functional and irreversible [33].
Although we did not assess the role of sympathetic nervous system (SNS) activity on FMD, increased SNS activity
has not been shown to blunt FMD response [6].
The novelty of our pilot research is in the application of CMR to this young cohort of patients with type 1
diabetes to look at early vascular changes. No literature exists for the study of CMR CFD modeling with fluid–
structure interaction for young diabetic patients. Functional assessment of thoracic aortic properties such as
aortic stiffness by CMR has been validated [27, 32]. Aquaro et al. [2], studying 85 healthy subjects (ages 15 to
greater than 60 years) by CMR, showed that there is progressive impairment of the elastic properties of the
aortic wall with aging (i.e., maximum rate of systolic distension and distensibility decrease progressively through
with age (p < 0.001) and pulse wave velocity increased). Others have applied this technique to the study of
patients with chronic renal disease, where increased arterial stiffness has been associated with mortality in
patients with chronic kidney disease. Aortic distensibility, measured by CMR using the methods employed here,

was an independent predictor of combined vascular events and mortality in this study of chronic renal patients.
Furthermore, AD predicted all cause mortality [26].
Our pilot study is unique in its use of CMR to study the central vasculature in a young diabetic population at risk
for premature atherosclerosis, showing that it is feasible to characterize differences in their central vasculature
when compared with controls. Regional TAWSS derived from patient-specific CFD modeling appeared
qualitatively different for type 1 diabetic subjects when compared with controls (Fig. 1). Vascular changes
appear heterogeneous in the youthful cohorts studied here; in this early phase, the impact of regional TAWSS
may not be detected by the more global measure of CMR aortic distensibility measured at one or two aortic
locations (AAo and DAoT). This altered vascular TAWSS may become more widespread throughout the aorta with
patient aging, the subject of future, powered, longitudinal study.
Low TAWSS is thought, from studies of adult subjects, to promote atherogenesis, as is elevated OSI, an index of
directional changes in wall shear stress. The importance of these parameters and their serial change with aging,
though, is not known. In our study of young type 1 diabetic patients, it appears that regional differences in
TAWSS exist when compared with controls and that higher TAWSS is seen in the ascending aorta, reaching
significance for several locations the transverse arch. In theory this could be explained by differences in CFD
simulation boundary conditions, but cardiac output, cardiac index, flow distributions to aortic branches, heart
rate and the portion of the period spent in systole did not differ between groups. Many cardiovascular risk
factors, including type 1 diabetes, induce physiological outward arterial remodeling (dilation) that begins in
response to overall higher initial laminar shear stress (Glagov phenomenon). As the vessels become inflamed,
remodeling becomes excessive, and the result is adverse shear stress in larger arteries [30]. In our study of
young patients, it is possible we are seeing this early remodeling, where wall shear stress is still high and the
aorta, which has begun to stiffen, has yet to dilate. Moreover, extension of the endothelial dysfunction observed
in this pilot study could prevent myogenic dilation in response to elevated TAWSS. Chronic and sustained
increased TAWSS may further contribute to endothelial dysfunction, which also progresses with age. Serial data,
while not part of the current study, may show that TAWSS changes with age, such that at the point of
adulthood, when plaque is apparent, TAWSS levels have transitioned and are low.
Mean ascending aortic distensibility for our type 1 diabetic cohort (9.8 ± 2.7 × 10−3 mmHg−1) differed from
controls (6.2 ± 2.4 × 10−3 mmHg−1, p = 0.006). At first glance, this implies a paradoxically more compliant aorta
for the diabetic cohort; yet upon further review, all values for diabetic subjects fall well within published normal
range, where for ages 15–20 years, females have aortic distensibility 13.2 ± 3.4 × 10−3 mmHg−1 (range 8.3–16.3)
and males 8.1 ± 2.9 × 10−3 mmHg−1 (range 6.5–12.7) [2, 43]. Published variability in this measure shows a mean
difference (±standard error, SE) of 3 % (±7 %) with 95 % confidence interval (CI) for limits of agreement of ±69 %
[8]. Thus, the differences in AAo distensibility seen here are not clinically meaningful. The diabetic cohort’s CFD
modeling, though, shows that there already appear to be regional differences in TAWSS, supporting the notion
that CFD modeling may be a more sophisticated method to assess regional vascular changes than is
distensibility.
When compared with aortic distensibility in adult diabetic patients (ages 48–64 years), where distensibility of
the aorta was lowest (~3.8–4 × 10−3 mmHg−1) versus adult controls without disease
(~5 × 10−3 mmHg−1), p = 0.011, our diabetic subjects’ aortic distensibility, though, appears better—as would be
expected for this younger group [35]. Arterial distensibility decreases with age, with increased wall stiffness of
the proximal aorta seen with increased age [1]. The decreasing aortic elasticity, observed with aging, has been
related to normal structural wall changes during aging, including increased intimal-medial thickness beginning
after birth and to the cycles of contraction and expansion of the vasculature in response to cardiac systole which
fragments elastic fibers in the wall, transferring of stress stiff collagen fibers [43].

Correlations seen here between reduced aortic distensibility and elevated venous biomarkers (elevated
homocysteine, HgbA1c, and hs-CRP) speak to the biochemical milieu which invokes inflammatory mechanisms
involved in the development of endothelial dysfunction. The regional nature of these correlations between
aortic distensibility and venous biomarkers is not unexpected, given the heterogeneous vascular changes seen
on CFD modeling. From a basic science perspective, hyperhomocysteinemia has been shown to induce smooth
muscle cell proliferation, endothelial dysfunction, collagen synthesis, and deterioration of elastic material of the
arterial wall [39]. Elevated plasma homocysteine has been shown to increase the risk of atherothrombosis,
especially in individuals with impaired glucose tolerance [16] and pediatric type 1 diabetic populations with
micro albuminuria [47]. The role of elevated hs-CRP in all stages of atherogenesis, including endothelial
dysfunction, atherosclerotic plaque formation, plaque maturation, plaque destabilization, and eventual rupture,
is well known [48]. Subjects with type 1 diabetes and control subjects had similar homocysteine and hs-CRP in
our pediatric pilot study suggesting early disease (or perhaps reflecting small sample size).

Limitations
This was a prospective, pilot study funded by an investigational grant; thus, subject enrollment was limited by
available funding. Control subjects were chosen from those with clinically indicated CMR scans, rather than
imaging “healthy children.” Careful attention was paid, though, to avoid those with congenital heart disease
affecting the aorta; in fact, in four controls, no cardiac disease existed at all, as ARVD was not found (3) and
pectus chest wall deformity did not affect the heart (1). One patient with repaired tetralogy of Fallot (a 13-yearold male) served as a control subject early in the course of this study. His left ventricular outflow tract was
normal and he had only trace aortic regurgitation with aortic dimensions just slightly above the normal range
[19]. The authors subsequently recognized that subsequent such subjects should not be permitted as controls.
Furthermore, the cross-sectional nature of the study allows characterization of the population, but limits
comment on the longitudinal significance of aortic distensibility and regional TAWSS and OSI.
CMR images for selected three-dimensional SSFP whole heart acquisitions were performed with the patient
breathing comfortably and with acquisition navigated off the position of the diaphragm; as such, these were
time-consuming (10–15 min acquisition time) acquisitions, leading to slight degradation in image quality for the
descending aorta near the diaphragm, truncating some CFD models (Figs. 1, 2). Three-dimensional data acquired
with gadolinium (Gd) dye (used for clinically indicated scans in controls) preserved image quality. As Gd does not
have Food and Drug Administration approval for cardiac imaging, it was not used for diabetic subjects, but only
for cases where its use was clinically indicated (controls). While this difference in technique for acquisition of the
3D aortic data set is a study limitation, others have shown that there is no significant difference in the
orthogonal measurements of the aortic diameter between those made on images from the 3D SSFP and those
made from the contrast enhanced MRA sequences [9].
Assumptions exist with CFD modeling which relies on definition of inlet and outlet boundary conditions, as
discussed in detail elsewhere (17). CFD results were considered mesh independent when TAWSS at several
regions in the aorta changed <1 % between successive simulations. Thus, while it is possible that the results
presented may differ for much larger meshes, it is unlikely that the key observations would be altered. Inclusion
of the AoV with CFD simulations has been shown to impact hemodynamics, but was not employed [45], because
valvular imaging was not conducted when the imaging data was collected.
In conclusion, while global measures of aortic distensibility obtained by CMR show no clinically meaningful
differences when young diabetic patients are compared with controls (with both having aortic distensibility
within the normal range), CFD determined regional TAWSS and OSI data appear qualitatively different. For outer
and right curvatures of the transverse aorta (just proximal to the origin of the LSCA), TAWSS and OSI were
significantly different for diabetics versus controls. CFD modeling, thus, shows promise as a method of

elucidating the early regional vascular changes in the aortic wall, when exposed to biochemical stresses of type 1
diabetes. Longitudinal CMR studies of children and young adults are warranted to better understand these
vascular changes and the cardiac burden imposed by type 1 diabetes.
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